Skip to content

INFIX'MEDICAL

Active Private limited companyfounded 2020active for 5 yearsPlace Communale 12, 6540 LobbesKBO/BCE: BE 0758.834.562 #10 company by total assets in Lobbes, Wholesale and retail trade sector

Lifetime

5 annual accounts with figures on one time axis
peak of €44,896 in 2025
€44,896▲ 436%
lowest -€1,799 in 2022
€23,053▲ 358%
peak of €30,241 in 2025
€30,241▲ 321%
€295,885▲ 12×
Board1 name since 2020
1 director
Documentsfilings and deeds
19-11-2026111 days late
2025micro format
Gross margin from €8,373 to €44,896Result from €5,037 to €23,053Equity from €7,188 to €30,241Debts from €23,685 to €295,885Cash from €25,112 to €35,713

Key points

from the 2025 annual accounts

Turnover

≈ €200,000 estimated

The micro format states no turnover.

Debts

€295,885 91% of the balance sheet
Suppliers 0%Taxes and wages 5%Other 95%

Of this, €295,485 falls due within a year.

Filings

5 annual accounts 111 days
AprilJune31 JulyOctober20222024

Latest accounts filed late: after the legal deadline.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,154 companies had the same profile as INFIX'MEDICAL has now. Each dot stands for 6 companies, two years later.

96.0%
were still trading
2.3%
stopped another way
1.7%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,154 companies, not a prediction for INFIX'MEDICAL. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • founderdeed of 01-12-2020
  • founderdeed of 01-12-2020
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0758834562
Registered office moved within Lobbes The registered office moved from Rue des Bonniers 42 à 6540 LOBBES to Place communale 12 à 6540 LOBBES · General meeting of 05-01-2024 · Gazette deed
Incorporation Founding capital of €2,000, 100 shares · Founded by ; · appointed as director · published on 01-12-2020 · Gazette deed
First establishment Place Communale 12, Lobbes
All 12 events

Comparable companies

same main activity, similar in size and age
Company
INFIX'MEDICAL Lobbes €326,126 €44,896 9.3% -
NATOREA Tournai €309,389 €40,847 38.1% -
Clinicare Shops Beveren-Kruibeke-Zwijndrecht €297,488 €41,646 72.9% -
NOVEA Muriel Gottschalk Liège €420,479 €43,501 1.1% -
Bellini Clinic Bree €486,442 €31,432 2.0% -
Sens-Unique Menen €432,486 €76,831 26.2% -
ELMAX MEDICAL Roeselare €257,014 €76,643 38.2% -

These companies have the same main activity as INFIX'MEDICAL: retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses (NACE 47741). They are comparable in size and age: total assets between €257,000 and €486,000, founded between 2020 and 2021.

Official details

Source: KBO
Status
Active since 27-11-2020Normal situation
Activity
Retail sale of medical and orthopaedic goods, excluding prescription glasses and lensesNACE 47741and 1 other
Establishment unit
2.310.225.2446540 Lobbes, since 27-11-2020
Financial year end
31 December
Peppol
Reachable since 06-10-2025
Company details

Annual accounts 2025

€326,126▲ 956%
Filing
Filed on 19-11-2026
Financials

Insights on INFIX'MEDICAL

INFIX'MEDICAL files the micro format. That format states no turnover. The gross margin rose from €241 in 2021 to €44,896 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about INFIX'MEDICAL

What is the company number of INFIX'MEDICAL?
The company number of INFIX'MEDICAL is 0758.834.562. The VAT number is the same number with BE in front: BE 0758.834.562.
Where is INFIX'MEDICAL based?
The registered office is at Place Communale 12, 6540 Lobbes.Company details
What does INFIX'MEDICAL do?
According to the KBO register, the main activity is retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses (NACE 47741).
What is the legal form of INFIX'MEDICAL?
INFIX'MEDICAL is a private limited company (BV).
When was INFIX'MEDICAL founded?
INFIX'MEDICAL was founded on 27-11-2020.
Is INFIX'MEDICAL still active?
Yes, INFIX'MEDICAL is an active enterprise in the KBO register.
What is the turnover of INFIX'MEDICAL?
The turnover in financial year 2025 is about €200,000. This figure is estimated from the gross margin of €44,896 and 56 comparable companies (NACE 477). It probably lies between €110,000 and €370,000.Financials
Is INFIX'MEDICAL profitable?
In financial year 2025, INFIX'MEDICAL made a profit of €23,053.
Where can I find the annual accounts of INFIX'MEDICAL?
INFIX'MEDICAL filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of INFIX'MEDICAL due?
INFIX'MEDICAL must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.